P3 Health Partners annual free cash flow
2019
2020
2021
2022
2023
2024
P3 Health Partners Free Cash Flow (FCF) History (PIII)
P3 Health Partners reported −$110.1M in free cash flow for fiscal 2024, a decrease of $32.3M from the previous fiscal year, with a free cash flow margin of −7.34%.
View full P3 Health Partners company overviewP3 Health Partners free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2024 | 2024-12-31 | −$110.1M | −$32.3M | — | −7.34% |
| 2023 | 2023-12-31 | −$77.9M | $50.4M | — | −6.15% |
| 2022 | 2022-12-31 | −$128.3M | −$73.8M | — | −12.22% |
| 2021 | 2021-12-02 | −$54.4M | −$26.9M | — | −9.41% |
| 2020 | 2020-12-31 | −$27.5M | $2.2M | — | −5.60% |
| 2019 | 2019-12-31 | −$29.7M | — | — | −20.44% |
P3 Health Partners quarterly free cash flow
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2024 | 2024-12-31 | −$57.2M | −$41.1M | — | −15.44% |
| Q3 2024 | 2024-09-30 | −$22.6M | −$14.6M | — | −6.25% |
| Q2 2024 | 2024-06-30 | −$10.2M | $19.8M | — | −2.70% |
| Q1 2024 | 2024-03-31 | −$20.0M | $4.2M | — | −5.16% |
| Q4 2023 | 2023-12-31 | −$16.1M | $15.9M | — | −4.64% |
| Q3 2023 | 2023-09-30 | −$8.0M | $13.9M | — | −2.77% |
| Q2 2023 | 2023-06-30 | −$30.0M | $15.8M | — | −9.13% |
| Q1 2023 | 2023-03-31 | −$24.2M | $4.5M | — | −8.01% |
| Q4 2022 | 2022-12-31 | −$32.0M | −$20.4M | — | −12.39% |
| Q3 2022 | 2022-09-30 | −$21.9M | −$15.1M | — | −8.80% |
| Q2 2022 | 2022-06-30 | −$45.8M | −$23.6M | — | −17.01% |
| Q1 2022 | 2022-03-31 | −$28.7M | −$14.9M | — | −10.47% |
| Q4 2021 | 2021-12-02 | −$11.6M | — | — | −9.17% |
| Q3 2021 | 2021-09-30 | −$6.8M | — | — | −4.36% |
| Q2 2021 | 2021-06-30 | −$22.2M | — | — | −15.38% |
| Q1 2021 | 2021-03-31 | −$13.8M | — | — | −9.11% |
P3 Health Partners free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from −$29.7M to −$110.1M, a net decrease of $80.4M. P3 Health Partners's latest reported quarter, Q4 2024, generated −$57.2M in free cash flow, a decrease of $41.1M year over year.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review P3 Health Partners filings at SEC.gov ↗